Related Experiment Video
Updated: Dec 4, 2025
Visualizing and Quantifying Endonuclease-Based Site-Specific DNA Damage
Published on: August 21, 2021
DNA mismatch repair in the chromatin context: Mechanisms and therapeutic potential
1Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas, 75390, USA.
Abstract:
DNA mismatch repair (MMR) maintains genomic stability primarily by correcting replication errors. Defects in MMR lead to cancers and cause resistance to many chemotherapeutic drugs. Emerging evidence reveals that MMR is coupled with replication and precisely regulated in the context of chromatin; strikingly, tumors defective in MMR are highly responsive to immune checkpoint blockade therapy. As a tribute to Dr. Samuel Wilson for his many scientific contributions to the field of DNA repair and his leadership as Editor-in-Chief of the journal DNA Repair, we summarize recent developments in research on MMR at the chromatin level, its implications for tumorigenesis, and its therapeutic potential.
Insights
DNA mismatch repair (MMR) maintains genomic stability by correcting replication errors. MMR defects are linked to cancer and drug resistance, but tumors with MMR deficiencies show promise for immunotherapy.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- DNA mismatch repair (MMR) is crucial for maintaining genomic stability by correcting DNA replication errors.
- MMR defects are associated with various cancers and can lead to resistance against chemotherapy.
- Recent research highlights the interplay between MMR, DNA replication, and chromatin regulation.
Purpose of the Study:
- To review recent advancements in understanding DNA mismatch repair (MMR) at the chromatin level.
- To explore the implications of MMR in tumorigenesis.
- To discuss the therapeutic potential of targeting MMR pathways.
Main Methods:
- Literature review of recent studies on DNA mismatch repair.
- Analysis of the relationship between MMR, replication, and chromatin.
- Examination of clinical data regarding MMR deficiency and therapeutic responses.
Main Results:
- MMR is intricately coupled with DNA replication and chromatin structure.
- Tumors with deficient MMR exhibit heightened sensitivity to immune checkpoint blockade therapy.
- Understanding MMR at the chromatin level offers new therapeutic avenues.
Conclusions:
- MMR plays a vital role in preventing cancer development.
- Targeting MMR pathways, particularly in the context of chromatin, holds significant therapeutic promise.
- MMR deficiency presents a predictive biomarker for immunotherapy response.
More Related Videos
09:14Examination of Proteins Bound to Nascent DNA in Mammalian Cells Using BrdU-ChIP-Slot-Western Technique
Published on: January 14, 2016
06:44Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
Published on: April 28, 2021
Related Concept Videos
01:36Mismatch Repair
01:20Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
02:25Overview of DNA Repair
Chemically...
02:25Overview of DNA Repair
01:38Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
01:08Nucleotide Excision Repair